Overview
- About three weeks after the FDA approved updated COVID-19 vaccines, HHS and the CDC have not opened federal ordering through the Vaccines for Children program or Section 317, blocking state requests for roughly half of U.S. children.
- HHS says it is still finalizing procurement decisions and that an arbitrary September deadline should not drive public-health action, so the agency has not yet authorized routine federal purchases.
- Pfizer and Moderna say pediatric doses have been shipped and retail pharmacies are offering shots for commercially insured patients, so supply exists even as federal access lags.
- The hold follows legal and administrative disruption of the CDC’s Advisory Committee on Immunization Practices after HHS replaced its members last year and a judge ruled that overhaul unlawful, leaving ACIP unable to complete its usual vaccine coverage votes.
- Public-health experts warn the delay will widen access gaps for low-income and uninsured families, could reduce uptake during a period of rising COVID activity, and underscores broader strain on the immunization system after falling pediatric vaccination rates and recent measles outbreaks.